News
Abcentra begins patient dosing in phase 2b FORTIFY trial evaluating orticumab in patients with cardiovascular disease: Los Angeles Wednesday, August 13, 2025, 18:00 Hrs [IST] Abce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback